• α-Amanitin for Testing RNA-Dependent Chromatin

  2026-09-26

  α-Amanitin can help test whether ongoing RNA polymerase II transcription is needed to maintain chromatin organization—not merely whether transcription and chromatin structure change together. This article connects the SAFB–major satellite RNA model to practical perturbation design, controls, and interpretation limits.

• HA mRNA Vaccine Protects Dairy Cows Against H5N1

  2026-09-25

  A hemagglutinin-encoding mRNA–lipid nanoparticle vaccine protected lactating dairy cows from H5N1 challenge shortly after immunization, with protection still observed in most animals at a later challenge time point. The findings support further evaluation of mRNA vaccination in cattle, while leaving important questions about durability, study scale, and vaccine formulation for subsequent trials.

• mRNA Vaccine Study in Lactating Dairy Cows

  2026-09-25

  This paper evaluates a hemagglutinin-based mRNA–LNP vaccine in lactating dairy cows, reporting immunogenicity and challenge outcomes while documenting the scope of the study.

• Canagliflozin and Renal Tubular Mitochondria

  2026-09-24

  A hypertensive–diabetic mouse study links canagliflozin treatment with improved proximal tubular mitochondrial structure and bioenergetic measures, most clearly in males. The findings extend the investigation of SGLT2 inhibition beyond glucose handling, while the short treatment period and sex-dependent response make careful replication essential.

• L. gasseri Protects the Gut Barrier in DSS Colitis

  2026-09-24

  In a mouse model of DSS-induced colitis, Lactobacillus gasseri ATCC33323 improved disease-associated inflammation and barrier injury, with E-cadherin emerging as a necessary component of protection. The study connects this effect to NR1I3-mediated regulation of CDH1 transcription, offering a mechanistic basis for further probiotic research while leaving human efficacy and several causal details unresolved.

• Alosetron and Intestinal Polarity: Separate the Signals

  2026-09-23

  Alosetron is a 5-HT3 receptor antagonist useful for studying serotonergic control of gastrointestinal function, but it is not a direct probe of intestinal stem-cell polarity. This article explains how to separate receptor-level effects from the CDC42–YAP–EGFR–mTOR program and design assays that distinguish them.

• 10 mM dNTP Mixture: PCR Workflow Guide

  2026-09-23

  Build more reproducible PCR, qPCR, sequencing, and DNA-template workflows with a balanced nucleotide stock designed for controlled polymerase reactions. This guide also explains how upstream DNA quality supports LNP delivery studies without confusing nucleotide synthesis with nanoparticle formulation or intracellular trafficking.

• Dynasore: Dynamin GTPase Inhibitor Guide

  2026-09-22

  Dynasore is a cell-permeable dynamin GTPase inhibitor used to test dynamin-dependent membrane fission and endocytosis. Its reversible pharmacology supports endocytosis research, but cellular conclusions require dose optimization, vehicle controls, viability measurements, and orthogonal validation.

• Cytarabine (AraC): Mechanism and Research Workflows

  2026-09-22

  Cytarabine, also called AraC, is a phosphorylated nucleoside analog that inhibits DNA synthesis and supports mechanistic studies of leukemia-cell apoptosis. This article separates established cytarabine biology from the distinct RIPK3-centered necroptosis mechanism reported in orthopoxvirus research.

• CB-839: Mapping Glutamine Dependence in Cancer

  2026-09-21

  CB-839 (Telaglenastat) is a selective GLS1 inhibitor for dissecting glutamine dependence, but its greatest value may be as a causal probe downstream of transcriptional and splicing stress. This article translates recent MYCN neuroblastoma findings into assay strategies for cancer metabolism research and preclinical cancer drug evaluation.

• Precision PCR for Environment-Linked Neurodegeneration

  2026-09-21

  Peng et al. revealed how early pheromone perception reshapes neuronal signaling and accelerates adult neurodegeneration in C. elegans. This article translates that mechanistic framework into a more rigorous PCR, genotyping, and sequencing strategy using HyperFusion™ high-fidelity DNA polymerase, while defining the limits of extrapolating model-organism findings toward human research.

• 5-Methyl-CTP: A Decision Framework for mRNA

  2026-09-20

  5-Methyl-CTP can support mRNA synthesis with modified nucleotides, but its value depends on transcript design, analytical controls, and biological context. This guide connects nucleotide selection with practical assay decisions and the latest mRNA vaccine evidence without conflating platform success with reagent-specific proof.

• Fluconazole Workflows for Fungal Resistance Research

  2026-09-19

  Build reproducible Fluconazole assays that connect ergosterol disruption with susceptibility, biofilm, and resistance phenotypes. This guide combines solvent handling, comparative controls, and resistance-aware interpretation for Candida albicans and emerging Candida models.

• HBPL Lipopolyplexes for Stable mRNA Delivery

  2026-09-18

  The reference study develops hyperbranched poly-L-lysine-based lipopolyplexes that combine high mRNA encapsulation, membrane-fusion-mediated uptake, intracellular release, and improved storage stability. Its results suggest that polymer architecture can help resolve the usual trade-off between nanoparticle durability and cytoplasmic mRNA availability, although broader translational validation remains necessary.

• 5-Methyl-CTP for mRNA Workflow Optimization

  2026-09-18

  Learn how 5-Methyl-CTP can be screened in vitro to support more durable, translation-ready mRNA. The workflow connects nucleotide selection with practical vaccine and mRNA drug development assays while clearly separating product-driven recommendations from evidence generated in dairy cattle.

549 records 3/37 page Previous Next 12345 下5页 Last page